X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (251) 251
Publication (10) 10
Book Review (9) 9
Newspaper Article (8) 8
Magazine Article (5) 5
Newsletter (5) 5
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (180) 180
humans (168) 168
aclidinium bromide (144) 144
pulmonary disease, chronic obstructive - drug therapy (144) 144
respiratory system (116) 116
chronic obstructive pulmonary disease (114) 114
obstructive pulmonary-disease (105) 105
tiotropium (105) 105
lung diseases, obstructive (101) 101
copd (99) 99
pharmacology & pharmacy (78) 78
administration, inhalation (75) 75
safety (75) 75
aclidinium (73) 73
pulmonary disease, chronic obstructive - physiopathology (73) 73
efficacy (71) 71
muscarinic antagonists - administration & dosage (69) 69
treatment outcome (64) 64
bronchodilator agents - administration & dosage (63) 63
male (61) 61
muscarinic antagonists - adverse effects (58) 58
muscarinic antagonists - therapeutic use (58) 58
drug therapy (55) 55
female (55) 55
middle aged (54) 54
bronchodilator agents - therapeutic use (51) 51
bronchodilator agents - adverse effects (48) 48
aged (46) 46
formoterol (46) 46
tropanes - administration & dosage (46) 46
pulmonary disease, chronic obstructive - diagnosis (45) 45
aclidinium bromide/formoterol fumarate (44) 44
double-blind (44) 44
tropanes - adverse effects (44) 44
care and treatment (40) 40
bronchodilators (39) 39
drug combinations (39) 39
copd patients (38) 38
drug therapy, combination (38) 38
lung - drug effects (38) 38
tropanes - therapeutic use (38) 38
dosage and administration (37) 37
diseases of the respiratory system (36) 36
forced expiratory volume (35) 35
research (35) 35
lung - physiopathology (34) 34
placebo (34) 34
adrenergic beta-2 receptor agonists - administration & dosage (33) 33
daily aclidinium bromide (32) 32
respiratory agents (32) 32
muscarinic antagonists - pharmacology (31) 31
respiratory tract diseases (31) 31
review (31) 31
time factors (31) 31
asthma (30) 30
quality of life (30) 30
fixed-dose combinations (29) 29
pharmacokinetics (29) 29
severity of illness index (29) 29
adrenergic beta-2 receptor agonists - therapeutic use (28) 28
animals (28) 28
lama (28) 28
adult (27) 27
double-blind method (27) 27
exacerbations (27) 27
clinical trials (26) 26
international journal of chronic obstructive pulmonary disease (26) 26
lung-function (26) 26
mortality (26) 26
analysis (25) 25
bromide (25) 25
glycopyrronium (25) 25
indacaterol (25) 25
bronchodilator agents - pharmacology (24) 24
fixed-dose combination (23) 23
tiotropium bromide (23) 23
adrenergic beta-2 receptor agonists - adverse effects (22) 22
pharmaceutical industry (22) 22
pulmonary/respiratory (22) 22
dose-response relationship, drug (21) 21
formoterol fumarate (21) 21
formoterol fumarate - administration & dosage (21) 21
medical research (21) 21
tropanes - pharmacology (21) 21
disease progression (20) 20
inhaled corticosteroids (20) 20
laba (20) 20
medicine, experimental (20) 20
muscarinic antagonists (20) 20
original research (20) 20
pulmonary and respiratory medicine (20) 20
delayed-action preparations (19) 19
drug administration schedule (19) 19
pharmacological characterization (19) 19
tropanes - pharmacokinetics (19) 19
umeclidinium/vilanterol 62.5/25 mcg (19) 19
bronchodilation (18) 18
muscarinic antagonist (18) 18
usage (18) 18
bronchodilator (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2014, Volume 28, Issue 2, pp. 114 - 121
Journal Article
JAMA, ISSN 0098-7484, 05/2019, Volume 321, Issue 17, pp. 1693 - 1701
Journal Article
Journal Article
Pulmonary Pharmacology and Therapeutics, ISSN 1094-5539, 2014, Volume 28, Issue 2, pp. 114 - 121
This study characterised the invitro and invivo profiles of two novel long-acting muscarinic antagonists, aclidinium bromide and glycopyrronium bromide, using... 
SAMA | Raw | LAMA | Muscarinic receptors | Glycopyrronium bromide (PubChem CID: 11693) | Long-acting muscarinic antagonists | Aclidinium bromide (PubChem CID: 11519741) | Preclinical | Tiotropium bromide (PubChem CID: 5487426) | Aclidinium | Glycopyrronium | Ipratropium bromide (PubChem CID: 31098) | COPD
Journal Article
Journal Article
Respiratory research, ISSN 1465-9921, 2014, Volume 15, Issue 1, pp. 123 - 123
Background: Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic... 
Formoterol | Dyspnea | Health status | Lung function | Aclidinium | COPD | MODERATE | HYPERINFLATION | BRONCHODILATION | MAINTENANCE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TIOTROPIUM | BROMIDE | ACCORD COPD | FLUTICASONE | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | North America | Recovery of Function | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Dry Powder Inhalers | Double-Blind Method | Drug Administration Schedule | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | New Zealand | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Aged | Australia | Health Status | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Pharmaceutical industry | Medical research | Studies | Heart attacks | Laboratories | Smooth muscle | Chronic obstructive pulmonary disease | Drug therapy | Research
Journal Article
Chromatographia, ISSN 0009-5893, 4/2017, Volume 80, Issue 4, pp. 559 - 563
A new CE method for separation of (R,S)-aclidinium bromide enantiomers has been developed and validated. In this method, sulphated γ-CD 4.8% (w/v) in acidic... 
Chemistry | Pharmacy | Proteomics | Chiral separation | Aclidinium bromide | Laboratory Medicine | Sulphated CD | Chromatography | CHEMISTRY, ANALYTICAL | DISEASE | BIOCHEMICAL RESEARCH METHODS | CAPILLARY-ELECTROPHORESIS | BRONCHODILATORS | Phosphates | Electrolytes | Cyclodextrins | Enantiomers | Silica
Journal Article
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 06/2011, Volume 20, Issue 6, pp. 871 - 873
Underlying inflammation in asthma increases the activity of the cholinergic nervous system, contributing to bronchoconstriction/airway hyper-responsiveness... 
experimental asthma | aclidinium bromide | inflammation | PHARMACOLOGY & PHARMACY | tiotropium bromide | MODEL | airways hyper-responsiveness | Taclidinium bromide
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2013, Volume 107, Issue 12, pp. 1957 - 1965
Journal Article
Journal Article